Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature

Cancer shared this article with you from Inoreader Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature Via Latest Results for Rare Cancers and Therapy Abstract Penile cancer is a rare condition, which mostly affects men in their sixth decade of life. The most common histology is squamous cell carcinoma (SCC), with about half of the cases linked to human papilloma virus (HPV) infection. The lack of awareness and significant social and psychological stigma associated with penile cancer often leads to delays in presentation, diagnosis and management. Timely multidisciplinary care at experienced centers is therefore critical for improving outcomes. For patients with advanced disease, treatment options are limited and prognosis remains poor. Large international efforts are underway to further define the optimal standards of care. Targeted therapies and immune checkpoint inhibitors could potentially play a role in advanced disease and are under evaluation in clinical trials. In this review, we discuss the current management of penile cancer and future directions. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.